|
HIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.15919504498174E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.36720004604041E-09 |
| Normal-vs-Stage2 |
2.45729999999167E-05 |
| Normal-vs-Stage3 |
2.57259999969506E-08 |
| Normal-vs-Stage4 |
6.07659999999344E-05 |
| Stage1-vs-Stage2 |
9.662000E-01 |
| Stage1-vs-Stage3 |
2.294800E-01 |
| Stage1-vs-Stage4 |
3.528800E-01 |
| Stage2-vs-Stage3 |
3.544400E-01 |
| Stage2-vs-Stage4 |
2.898400E-01 |
| Stage3-vs-Stage4 |
5.940000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.48190040636121E-10 |
| Normal-vs-AfricanAmerican |
6.85150000068191E-08 |
| Normal-vs-Asian |
8.844600E-04 |
| Caucasian-vs-AfricanAmerican |
5.316200E-01 |
| Caucasian-vs-Asian |
3.621200E-01 |
| AfricanAmerican-vs-Asian |
2.936600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85484960724125E-12 |
| Normal-vs-Female |
2.4600999999902E-05 |
| Male-vs-Female |
4.441700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.06899997134968E-09 |
| Normal-vs-Extreme_Weight |
1.49740000399134E-08 |
| Normal-vs-Obese |
6.47340000048402E-07 |
| Normal-vs-Extreme_Obese |
3.763300E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.902600E-01 |
| Normal_Weight-vs-Obese |
9.766000E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.255800E-01 |
| Extreme_Weight-vs-Obese |
3.043000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.136400E-01 |
| Obese-vs-Extreme_Obese |
4.447400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.01640000002867E-06 |
| Normal-vs-Age(41-60Yrs) |
3.17779999980949E-07 |
| Normal-vs-Age(61-80Yrs) |
5.66546809466217E-13 |
| Normal-vs-Age(81-100Yrs) |
4.88409999999107E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.502600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.557600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.363700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.656400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.567600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.803200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.52810044804642E-10 |
| Normal-VS-Type2 PRCC |
1.54550039432877E-10 |
| Normal-VS-KIRP CIMP |
2.723800E-03 |
| Normal-VS-Unclassified PRCC |
3.7505999999965E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.561800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.257000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.807400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.728200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.078590E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.934400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.71230054976957E-10 |
| Normal-vs-N1 |
2.00240000000074E-05 |
| Normal-vs-N2 |
2.059800E-01 |
| N0-vs-N1 |
6.385700E-02 |
| N0-vs-N2 |
7.124800E-03 |
| N1-vs-N2 |
2.835800E-01 |
|
|
